Protocol Efficacy of blended digital and face-to-face psychotherapy compared to enhanced psychotherapy for patients with [SSD] (iSOMA+): 2026 Jutzi et al

Andy

Senior Member (Voting rights)
Full title: Efficacy of blended digital and face-to-face psychotherapy compared to enhanced psychotherapy for patients with Somatic Symptom Disorder (iSOMA+): study protocol for a multicenter randomized controlled pragmatic trial

Abstract

Background

Persistent somatic symptoms (PSS) that occur in various somatic, functional, or mental health conditions can lead to considerable psychological distress and functional impairment. As such, they are a key characteristic of the Somatic Symptom Disorder (SSD) in DSM-5. While psychological treatments such as cognitive behavioral approaches can address these symptoms, their clinical efficacy in reducing symptom burden in previous trials remains limited. Blended psychotherapy, i.e., combining face-to-face psychotherapy with digital elements, is a promising new approach to efficiently enhance psychotherapeutic effects. This study therefore aims to evaluate the efficacy, mechanisms, and safety of blended psychotherapy compared to enhanced standard psychotherapy for individuals with SSD in outpatient psychotherapy.

Methods

A two-armed, multicenter randomized controlled pragmatic trial will be conducted, and N = 250 adults with SSD will be randomized to either blended psychotherapy (20 individual sessions of cognitive behavioral therapy (CBT) + accompanying digital intervention; iSOMA+) or enhanced CBT (20 sessions of CBT + self-help booklet; CBT+). Participants are recruited at eight German university outpatient psychotherapy clinics. Assessments will be conducted at patient study inclusion (pre-treatment), during treatment, post-treatment, and 6 months follow-up. The primary outcome is the reduction in somatic symptom severity using the Screening for Somatoform Disorders (SOMS-7R) from baseline to post-treatment. Secondary outcomes include changes in symptom-related distress, coping, self-efficacy, as well as depression, anxiety, health anxiety, disability, quality of life, interpersonal relationship experiences and patient safety. Additionally, several potential moderators and mediators, including patient and intervention characteristics, will be examined.

Discussion

This trial investigates the potential of blended CBT for improving treatment outcomes in patients with SSD and will provide evidence on the effects of active vs. passive self-help as treatment augmentation under pragmatic care conditions. By identifying prescriptive factors of treatment response, the study will support personalized care and contribute to more accessible and efficacious treatment options for patients with PSS.

Open access
 
While psychological treatments such as cognitive behavioral approaches can address these symptoms, their clinical efficacy in reducing symptom burden in previous trials remains limited
In more complex cases, for example, with debilitating somatic symptoms and/or severe psychological comorbidity, targeted psychological and pharmacological interventions are indicated [17, 18]. Among these, the best evidence exists for cognitive behavioral therapy (CBT) in reducing symptom severity, distress, and functional impairment [19].
However, the efficacy of psychotherapeutic treatment options remains suboptimal, with only small to moderate effects compared to control groups according to meta-analyses of previous RCTs
Their efficacy remains limited, and this is the best evidence that exists, something that is both standardized and suboptimal, does not mean what they think it does, but the one simple trick is that nothing matters anyway, no one cares about outcomes here, no one actually expects anything out of this, because it's the same generic trash that has become standardized despite lacking any evidence of validity, let alone efficacy.
Moreover, access to adequate care remains challenging [21], with patients often perceived as “difficult to treat” and many affected individuals remain psychologically untreated
This has nothing to do with access. I don't think they ever think once about anything they write about, it's just incoherent nonsense. Although access issues are fundamental to this entire set of models, because no health care system could ever fund more than 1-5% of the access needed to match the scale of the target population.
Nonetheless, the superiority of blended psychotherapy is assumed, given the multimedial and interactive design as well as further persuasive, that is, engagement-enhancing, features of iSOMA (i.e., automatic reminders, progress bar, unlocking achievements), compared to passive bibliotherapy
Ah, well, let' just dispense with this charade and start the promotional campaign, then. You just slap that "QC passed" sticker on it and call it a day, why even bother having a quality assurance process if it works just the same?
In both conditions, patients receive health insurance-covered outpatient individual psychotherapy, based on an established and efficacious CBT manual for PSS and somatoform disorders
The "established and efficacious" stuff that remains limited and is suboptimal? They trying to "fill the gaps" in care provisioning, by copy-pasting the same old suboptimal junk that has been used in standard practice for decades. Makes sense when you don't think about it.
An overarching goal of the treatment is to enhance patients’ motivation to explore further biopsychosocial explanations for their bodily symptoms and to identify self-efficacious strategies for reducing and managing symptoms and functional disability.
They call this patient-centered evidence-based medicine. Probably first as a joke, I assume, and things got out of hand. The protocol is the exact same junk as usual, the exact same as in the suboptimal CBT they are pretending is a different thing by adding a + to it.

There has truly never been a more obvious candidate for downsizing, for addition by subtraction, than this wretched ideology. No group of highly-paid professionals have ever made a more blatant demonstration of the uselessness of their jobs than this. It's actually ostentatious in its celebration of waste and failure.
 
20 sessions of CBT to supposedly make some physical symptoms improve. That's an awful lot of talking. I wonder what on earth they do in all those sessions. Surely it's already been shown that it only takes a few sessions to persuade people to fill in questionnaires differently. Graham managed it in one short video.
Session 1–2Symptom monitoring, goal settingMy compass
Session 3–4Education on stress reaction (e.g., autonomous nervous system, symptom influence), relaxation exercisesStress and the body
Session 5–7Attention modification, behavioral activationShifting focus
Session 8–12Cognitive restructuringChanging perspectives
Session 13–16Reduction of illness behavior (e.g., reinsurance-, safety, avoidance behavior), graded physical exerciseFinding strength
Session 17–19Stress management, education on transactional stress model, stress-coping, communication skillsSolving problems and strengthening relationships
Session 20Summary and self-managementFit for the future
Somehow this is supposed to be different from a slightly different way of framing the same underlying concepts. Or, more accurately, it just doesn't matter what's in the box, the process here is to manufacture boxes that have already been sold.
 
Back
Top Bottom